Jeff Vengley

Jeff Vengley has extensive experience in the pharmaceutical and biotechnology sectors, currently serving as Region Business Director for the West at Cytokinetics since November 2021. Prior to this role, Vengley held the position of National Sales Director for the West at Esperion from August 2019 to October 2021, and was Vice President of Sales at Pernix Therapeutics from 2017 to 2019. Vengley's tenure at Depomed, Inc. from 2011 to 2017 included roles as Vice President of Managed Markets and Trade, as well as Vice President of Commercial Operations. Vengley also worked at Gilead Sciences as Director of Sales Force Effectiveness from 2008 to 2011, and spent over a decade at Merck in various capacities, culminating as Senior Manager of Sales Strategic Planning for Hospital, Vaccine, and HIV Specialty Sales Teams. Educational background includes a Bachelor of Arts in Political Science from California Polytechnic State University-San Luis Obispo. Vengley's achievements include multiple awards for sales performance and leadership.